Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2008
11/25/2008US7456267 Anticarcinogenic agents; nervous system disorders, urogenital disorders; improved biocompatibility
11/25/2008US7456263 P53 binding T cell receptor molecules
11/25/2008US7456257 Fusion proteins of interferon alpha muteins with improved properties
11/25/2008US7456256 Fibronectins; drug screening; treating cardiovascular/nervous system disorders
11/25/2008US7456255 Nogo receptor homologs that decrease inhibition of axonal elongation
11/25/2008US7456254 polyglycolic acid or polylactic acid or glycolic acid-lactic acid copolymer as biocompatible polymer having dispersed therein about 3%-5% (w/w) exendin-4 and about 2% (w/w) sucrose; antidiabetic agent
11/25/2008US7456253 Growth hormone releasing peptides
11/25/2008US7456252 Synthetic peptides to treat an autoimmune demylinating disease e.g., multiple sclerosis; an amino acid sequence having two tyrosine residues and a lysine complex with the myelin basic protein to modulate an immune response
11/25/2008US7456219 Polymorphs of suberoylanilide hydroxamic acid
11/25/2008US7456159 For delivering therapeutically effective amount of a drug that includes a parent drug and a prodrug; for delivering steroids
11/25/2008US7456155 2′-C-methyl-3′-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections
11/25/2008US7456154 Antisense oligonucleotide against human acetylcholinesterase (AChE) and uses thereof
11/25/2008US7456153 Comprise at least a tryptophan-containing cell adhesion recognition sequence; cancer modulating agent
11/25/2008US7456152 Peptide inhibitors of thrombin as potent anticoagulants
11/25/2008US7456151 Promoting angiogenesis with netrin1 polypeptides
11/25/2008US7456150 Pulmonary delivery of active fragments of parathyroid hormone
11/25/2008US7456149 ALK7 and myostatin inhibitors and uses thereof
11/25/2008US7456148 Using apolipoprotein as therapeutic agent which prevents and treats thrombosis in cardiovascular and ischemia-reperfusion injuries
11/25/2008US7456147 Controlled release of active agents utilizing repeat sequence protein polymers
11/25/2008US7456146 Anticarcinogenic agents for use in the treatment of cancer
11/25/2008US7455994 Methods for producing Marburg virus proteins
11/25/2008US7455991 Serpentine transmembrane antigens expressed in human cancers and uses thereof
11/25/2008US7455989 AKAP84 and its use for visualization of biological structures
11/25/2008US7455986 Heparinase III and methods of specifically cleaving therewith
11/25/2008US7455984 Immunoreactive and immunotherapeutic molecules
11/25/2008US7455977 Methods of determining the level of human TBP-II with anti-TBP-II antibody
11/25/2008US7455845 Use of neurotoxin therapy for treatment of urologic and related disorders related to lowering elevated bladder pressure
11/25/2008US7455843 useful for enhancing immune response to antigens; vaccines; applicable to mucosal immunization in humans
11/25/2008US7455840 Inhibition of drug resistance to quinolone antibiotics by administering to the bacteria a quinolone and an agent that inhibits LexA, thereby inhibiting an SOS response pathway in the bacteria e.g. dipeptide Ala-Ala, alanylalanine or the gene/proteins PsiB, DinI
11/25/2008US7455837 Compositions and methods for the diagnosis and treatment of sepsis
11/25/2008US7455836 Administering an agent which antagonizes the effects of a colony stimulating factor on these monocyte/macrophage cells to lower levels or reduce their activity; treating inflammation
11/25/2008US7455835 Administering soluble cytotoxic t-lymphocyte associated antigen (ctla4) molecule that binds a cell surface B7 molecule
11/25/2008US7455833 Antitumor, anticancer agents; complexing phosphatide with antibody, duramycin; prevent reproduction of virus
11/25/2008US7455155 Impact absorbent assembly in slope protection systems
11/25/2008CA2433878C Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
11/25/2008CA2375549C Delivery system for biological material
11/25/2008CA2345354C Antisense modulation of bcl-x expression
11/25/2008CA2336376C Microparticle formulation for inhalation
11/25/2008CA2333252C Use of bromelain proteases for inhibiting blood coagulation
11/25/2008CA2323687C Mutant recombinant allergens
11/25/2008CA2276606C Method of treating prostatic diseases using active vitamin d analogues
11/25/2008CA2268029C Therapeutic and diagnostic applications of laminin and laminin-derived protein fragments
11/25/2008CA2264776C Stable protein and nucleic acid formulations using non-aqueous, anhydrous, aprotic, hydrophobic, non-polar vehicles with low reactivity
11/25/2008CA2204406C Lipid metabolism improving agent
11/25/2008CA2140971C A stable freeze-dried hirudin composition
11/20/2008WO2008141176A1 Methods of treatment of skin ulcers
11/20/2008WO2008141155A1 Compositions for protein delivery and methods of use thereof
11/20/2008WO2008141012A2 Quaternary alkyl ammonium bacterial efflux pump inhibitors and therapeutic uses thereof
11/20/2008WO2008141010A2 Polybasic bacterial efflux pump inhibitors and therapeutic uses thereof
11/20/2008WO2008140973A1 Semi-synthetic glycopeptides with antibacterial activity
11/20/2008WO2008140834A2 Novel antimicrobial peptides
11/20/2008WO2008140828A1 Inhibitors of acetyl-coa carboxylase for treatment of neuronal hypometabolism
11/20/2008WO2008140794A1 Hormone normalization therapy and uses thereof
11/20/2008WO2008140703A2 Synthetic peptide materials for joint reconstruction, repair and cushioning
11/20/2008WO2008140602A2 USE OF ANTAGONISTS OF THE INTERACTION BETWEEN HIV GP120 AND α4β7 INTEGRIN
11/20/2008WO2008140594A2 Peptide nanoparticles and uses therefor
11/20/2008WO2008140335A2 Methods of immune or hematological enhancement, inhibiting tumour formation or growth, and treating or preventing cancer, cancer symptoms, or the symptoms of cancer treatments
11/20/2008WO2008140125A1 Pharmaceutical composition for prevention of peritoneal fibrosis
11/20/2008WO2008140081A1 Liposome and method for producing liposome
11/20/2008WO2008140041A1 Novel antiphlogistic-analgesic agent
11/20/2008WO2008140026A1 Novel leukotriene receptor antagonist
11/20/2008WO2008139986A1 New cyclic peptide compounds
11/20/2008WO2008139947A1 Prophylactic or therapeutic agent for diarrhea
11/20/2008WO2008139314A1 Compositions and methods for treating joint disorders
11/20/2008WO2008139243A1 Vm23 and vm24, two scorpion peptides that block human t-lymphocyte potassium channels (sub-type kv1.3) with high selectivity and decrease the in vivo dth-responses in rats
11/20/2008WO2008138994A1 Anti-tumor drug, medicament, composition, and use thereof
11/20/2008WO2008138620A2 1-aminocyclopentane-1,3,4-tricarboxylic acids derivatives
11/20/2008WO2008138612A2 Substrate promoting angiogenesis
11/20/2008WO2008138348A1 Preparation of complexed lactalbumin
11/20/2008WO2008138229A1 Recombinant protein expression system with enhanced yield and immunogenicity
11/20/2008WO2008138131A1 Bone targeted alkaline phosphatase, kits and methods of use thereof
11/20/2008WO2008138120A1 Avian influenza h5n1 hemagglutilin pseudotyped lentiviral vector system for rapid identification of antivirals and neutralizing polypeptides
11/20/2008WO2008121563A3 Modified fgf-21 polypeptides and their uses
11/20/2008WO2008118387A3 Erythrocyte atp-release modulators
11/20/2008WO2008116078A9 Stimulation of an immune response by cationic lipids
11/20/2008WO2008115631A9 Plant-produced compositions for treating papillomavirus infection and related methods
11/20/2008WO2008109433A3 Anti-angiogenic peptides
11/20/2008WO2008108673A3 Use of a peptide and an analgesic pharmaceutical agent
11/20/2008WO2008106644A3 Treatment of diseases characterized by inflammation
11/20/2008WO2008106076A3 Methods for monitoring disease progression of alzheimer's disease using csf markers from longitudinal samples
11/20/2008WO2008106074A3 Methods of treating infection
11/20/2008WO2008103146A3 Treating atherosclerosis
11/20/2008WO2008101104A3 Aligned nanofibers and related methods of use
11/20/2008WO2008098183A3 Combination therapy for treating cancer
11/20/2008WO2008097854A3 Method and substances for treating hpv infection
11/20/2008WO2008094493A3 Compositions containing lactoferrin and calcium, and methods of using same
11/20/2008WO2008092153A3 Modification of exosomal components for use as a vaccine
11/20/2008WO2008092084A3 Injectable non-aqueous suspension with high concentration of therapeutic agent
11/20/2008WO2008089494A3 Methods of use of epsilon inhibitor compounds for the attenuation of pain
11/20/2008WO2008088823A3 Methods for treating psoriasis
11/20/2008WO2008085982A3 Methods and compositions for treating hypoglycemic disorders
11/20/2008WO2008085828A3 Peptide modulators of angiogenesis and use thereof
11/20/2008WO2008073333A3 Vaccine for periodontitis and methods of use
11/20/2008WO2008064239A3 Imidazolidine derivative mass tags
11/20/2008WO2008051475A3 Hcv ns3 protease inhibitors
11/20/2008WO2008043033A3 Fibrillation-resistant insulin and insulin analogues
11/20/2008WO2008036929A3 Complex for transferring an anionic substance into a cell
11/20/2008WO2008033417A3 Methods and compositions for sealing and adhering biological tissues and medical uses thereof
11/20/2008WO2008031817A3 Histone deacetylase inhibitors with combined activity on class-i and class-iib histone deacetylases in combination with proteasome inhibitors
11/20/2008WO2008024435A3 Dendritic molecular intracellular transporters and methods of making and using same
1 ... 866 867 868 869 870 871 872 873 874 875 876 877 878 879 880 881 882 883 884 885 886 ... 3163